A device history record review of the reported lot number(s) confirmed that the product was produced accomplishing quality requirements and released according to established procedures.One decontaminated sample without original package or lot number was received at the manufacturing plant for evaluation.The reported issue was confirmed.After performing visual inspection per procedure, the issue was observed in the syringe broke.The syringe component is produced by external supplier and the assembly process consists in a pick and place operation.There is no additional inspection on the line to detect the condition reported.A formal investigation was open in order to determine the root cause and implement the appropriated corrective action(s); it was initiated to the supplier.The capa is currently in phase open investigation.Preventive action awareness training was performed to all personnel to ensure they are aware about this reported condition.
|